Abstract
Abstract
Purpose
Dopamine transporter (DAT) imaging with 123I-FP-CIT SPECT is used to support the diagnosis of Parkinson’s disease (PD) in clinically uncertain cases. Previous studies showed that automatic classification of 123IFPCIT SPECT images (marketed as DaTSCAN) is feasible by using machine learning algorithms. However, these studies lacked sizable use of data from routine clinical practice. This study aims to contribute to the discussion whether artificial intelligence (AI) can be applied in clinical practice. Moreover, we investigated the need for hospital specific training data.
Methods
A convolutional neural network (CNN) named DaTNet-3 was designed and trained to classify DaTSCAN images as either normal or supportive of a dopaminergic deficit. Both a multi-site data set (n = 2412) from the Parkinson’s Progression Marker Initiative (PPMI) and an in-house data set containing clinical images (n = 932) obtained in routine practice at the St Antonius hospital (STA) were used for training and testing. STA images were labeled based on interpretation by nuclear medicine physicians. To investigate whether indeterminate scans effects classification accuracy, a threshold was applied on the output probability.
Results
DaTNet-3 trained with STA data reached an accuracy of 89.0% in correctly identifying images of the clinical STA test set as either normal or with decreased striatal DAT binding (98.5% on the PPMI test set). When thresholded, accuracy increased to 95.7%. This increase was not observed when trained with PPMI data, indicating the incorrect images were confidently classified as the incorrect class.
Conclusion
Based on results of DaTNet-3 we conclude that automatic interpretation of DaTSCAN images with AI is feasible and robust. Further, we conclude DaTNet-3 performs slightly better when it is trained with hospital specific data. This difference increased when output probability was thresholded. Therefore we conclude that the usability of a data set increases if it contains indeterminate images.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Global regional. Lancet Neurol. 2018;17:939–53. https://doi.org/10.1016/S1474-4422(18)30295-3. and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
2. Interobserver reproducibility of the interpretation of I-123 FP-CIT single-photon emission computed tomography;Tondeur MC;Nucl Med Commun,2010
3. Diagnostic performance of the visual reading of123I-ioflupane SPECT images with or without quantification in patients with movement disorders or dementia;Booij J;J Nucl Med,2017
4. Refining diagnosis of Parkinson’s disease with deep learning-based interpretation of dopamine transporter imaging;Choi H;NeuroImage Clin,2017
5. Ding J-E, Chu C-H, Huang M-N, Lo, Hsu C-C. Dopamine Transporter SPECT Image Classification for Neurodegenerative Parkinsonism via Diffusion Maps and Machine Learning Classifiers. 2021. https://arxiv.org/abs/2104.02066. Accessed May 2021.